Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-08 3:09 pm Purchase | 2022-12-30 | 13G | Silence Therapeutics plc SLN | GOLDMAN SACHS GROUP INC GS | 4,541,163 5.100% | 4,541,163 (New Position) | Filing History |
| 2022-10-20 4:01 pm Purchase | 2022-08-16 | 13D | Silence Therapeutics plc SLN | Griffiths Richard Ian | 27,373,392 25.420% | 1,904,121 (+7.48%) | Filing History |
| 2022-08-22 4:13 pm Purchase | 2022-08-12 | 13G | Silence Therapeutics plc SLN | Deep Track Capital, LP | 5,854,740 5.440% | 5,854,740 (New Position) | Filing History |
| 2022-08-19 4:30 pm Purchase | 2022-08-12 | 13G | Silence Therapeutics plc SLN | TCG Crossover Management LLC | 6,314,625 5.900% | 6,314,625 (New Position) | Filing History |
| 2022-07-20 4:00 pm Purchase | 2022-07-19 | 13D | Silence Therapeutics plc SLN | Griffiths Richard Ian | 25,469,271 28.400% | 1,187,562 (+4.89%) | Filing History |
| 2022-06-15 4:31 pm Purchase | 2022-06-08 | 13D | Silence Therapeutics plc SLN | Griffiths Richard Ian | 24,281,709 27.000% | 3,585,357 (+17.32%) | Filing History |
| 2022-02-14 4:57 pm Sale | 2021-12-31 | 13G | Silence Therapeutics plc SLN | Quested Robert | 7,004,127 7.810% | -616,152 (-8.09%) | Filing History |
| 2022-02-14 4:54 pm Sale | 2021-12-31 | 13G | Silence Therapeutics plc SLN | Griffiths Richard Ian | 20,696,352 23.050% | -169,496 (-0.81%) | Filing History |
| 2022-02-10 4:44 pm Sale | 2021-12-31 | 13G | Silence Therapeutics plc SLN | Lombard Odier Asset Management (USA) Corp | 10,417,563 11.600% | -503,008 (-4.61%) | Filing History |
| 2022-02-07 4:01 pm Purchase | 2021-12-31 | 13G | Silence Therapeutics plc SLN | Mallinckrodt plc MNKTQ | 5,062,167 5.640% | 5,062,167 (New Position) | Filing History |
| 2022-01-27 2:51 pm Purchase | 2021-12-31 | 13G | Silence Therapeutics plc SLN | GOLDMAN SACHS GROUP INC GS | 4,828,417 5.400% | 4,828,417 (New Position) | Filing History |
| 2021-02-17 3:53 pm Purchase | 2020-12-31 | 13G | Silence Therapeutics plc SLN | Keith Robert Napier | 12,287,964 13.700% | 12,287,964 (New Position) | Filing History |
| 2021-02-17 3:47 pm Purchase | 2020-12-31 | 13G | Silence Therapeutics plc SLN | Griffiths Richard Ian | 20,865,848 23.300% | 20,865,848 (New Position) | Filing History |
| 2021-02-17 3:46 pm Purchase | 2020-12-31 | 13G | Silence Therapeutics plc SLN | Quested Robert | 7,620,279 8.500% | 7,620,279 (New Position) | Filing History |
| 2021-02-12 6:02 pm Purchase | 2020-12-31 | 13G | Silence Therapeutics plc SLN | Lombard Odier Asset Management (USA) Corp | 10,920,571 12.200% | 10,920,571 (New Position) | Filing History |